Evidence for the existence of imidazoline-specific binding sites in synaptosomal plasma membranes of the bovine brainstem

Journal of Neurochemistry

Volumn 71, Issue 5, 1998, Pages 2193-2202

  Heemskerk, F M J ^a   Dontenwill, M ^a   Greney, H ^a   Vonthron, C ^a   Bousquet, P ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Clonidine; Electron microscopy; Imidazoline receptors; Monoamine oxidase; Synaptosomes; 2 Adrenoceptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); CELL SURFACE RECEPTOR; CLONIDINE; IMIDAZOLINE;

ANIMAL CELL; ARTICLE; BINDING SITE; BRAIN STEM; BRAIN SYNAPTOSOME; CATTLE; CELL ULTRASTRUCTURE; DRUG RECEPTOR BINDING; ELECTRON MICROSCOPY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SYNAPTIC MEMBRANE;

EID: 0031752441     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71052193.x     Document Type: Article

References (36)

1. 2 imidazoline-preferring receptors. Br. J. Pharmacol. 14, 837-845.
2. Bousquet P. (1995) Recent advances in imidazoline receptor research. Exp. Opin. Invest. Drugs 4, 431-442.
3. Bousquet P., Feldman J., and Schwartz J. (1984) Central cardiovascular effects of α adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230, 232-236.
4. Bricca G., Dontenwill M., Molines A., Feldman J., Belcourt A., and Bousquet P. (1988) Evidence for the existence of a homogeneous population of imidazoline receptors in the human brainstem. Eur. J. Pharmacol. 150, 401-402.
5. Bricca G., Dontenwill M., Molines A., Feldman J., Belcourt A., and Bousquet P. (1989) The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur. J. Pharmacol. 162, 1-9.
6. 2-adrenergic receptors in the hypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. J. Pharmacol Exp. Ther. 273, 1162-1171.
7. 2 sites. J. Pharmacol. Exp. Ther. 272, 681-688.
8. Dunkley P. R., Jarvie P. E., Heath J. W., Kidd G. J., and Rostas J. A. P. (1986) A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res. 372, 115-129.
9. Dunkley P. R., Heath J. W., Harrison S. M., Jarvie P. E., Glenfield P. J., and Rostas J. A. P. (1988) A rapid Percoll gradient procedure for isolation of synaptosomes directly from an S1 fraction: homogeneity and morphology of subcellular fractions. Brain Res. 441, 59-71.
10. 1-imidazoline binding sites. Neurochem. Int. 30, 17-23.
11. Ernsberger P. R., Meeley M. P., Mann J. J., and Reis D. J. (1987) Clonidine binds to imidazoline binding sites as well as alpha2-adrenoceptors in ventrolateral medulla. Eur. J. Pharmacol. 134, 1.
12. Ernsberger P. R., Giuliano R., Willette R. N., and Reis D. J. (1990) Role of imidazoline receptors in the vasodepressor response to clonidine analogues in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253, 408-418.
13. Ernsberger P. R., Damon T. H., Graff L. M., Schaefer S. G., and Christen M. O. (1993) Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. J. Pharmacol. Exp. Ther. 264, 172-182.
14. 1-imidazoline receptors: definition, characterization, distribution and transmembrane signalling. Ann. NY Acad. Sci. 763, 22-42.
15. 3H]idazoxan. Neurosci. Lett. 184, 133-136.
16. Gordon-Weeks P. R. (1987) Isolation of synaptosomes, growth cones and their subcellular components, in Neurochemistry (Turner A. J. and Bachelard H. S., eds), pp. 1-26. IRL Press, Oxford.
17. 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives. Naunyn Schmiedebergs Arch. Pharmacol. 343, 271-282.
18. Limon I., Coupry I., Lanier S. M., and Parini A. (1992) Purification and characterization of mitochondrial imidazoline-guanidium receptor site from rabbit kidney. J. Biol. Chem. 267, 21645-21649.
19. 2 imidazoline receptors. Br. J. Pharmacol. 116, 1729-1736.
20. 3H]idazoxan binding sites in the frontal cortex of depressed suicide victims. Biol. Psychiatry 34, 498-501.
21. Meeley M. P., Ernsberger P. R., Granata A. R., and Reis D. J. (1986) An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci. 38, 1119-1126.
22. 3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. J. Pharmacol. Exp. Ther. 264, 1187-1197.
23. 1 imidazoline sites in bovine adrenal medullary membranes. Naunyn Schmiedebergs Arch. Pharmacol. 348, 70-76.
24. 3H]clonidine binding sites in rat stomach: high affinity of imidazolines, guanidines and sigma ligands. Naunyn Schmiedebergs Arch. Pharmacol. 351, 561-564.
25. 3H]-idazoxan binding sites in the rat brain. Br. J. Pharmacol. 108, 597-603.
26. Piletz J. E. and Sletten K. (1993) Nonadrenergic imidazoline binding sites on human platelets. J. Pharmacol. Exp. Ther. 267, 1493-1502.
27. 1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J. Pharmacol. Exp. Ther. 279, 694-702.
28. 2-type receptors: pharmacological characterization and relationship to monoamine oxidase. Br. J. Pharmacol. 109, 625-631.
29. 2 with monoamine-oxidase-B sites. J. Neurochem. 61, 881-889.
30. Schultz A. and Hasselblatt A. (1988) An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors. Naunyn Schmiedbergs Arch. Pharmacol. 340, 321-327.
31. Tesson F., Prip-Buus C., Lemoine A., Pegorier J. P., and Parini A. (1991) Subcellular distribution of imidazoline-guanidinium receptive sites in human and rabbit liver. J. Biol. Chem. 266, 155-160.
32. Tesson F., Limon I., and Parini A. (1992) Tissue-specific localization of mitochondrial imidazoline guanidium receptive sites. Eur. J. Pharmacol. 219, 335-338.
33. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270, 9856-9861.
34. Thorne B., Wonnacott S., and Dunkley P. R. (1991) Isolation of hippocampal synaptosomes on Percoll gradients: cholinergic markers and ligand binding sites. J. Neurochem. 56, 479-484.
35. Tibiriça E., Mermet C., Feldman J., Gonon F., and Bousquet P. (1989) Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach. J. Pharmacol. Exp. Ther. 250, 642-647.
36. 3H]-idazoxan binding sites (I-receptors) occurs to interacting or interconvertible affinity forms of receptor. Pharmacol. Toxicol. 70, 208-219.